Pharma Market Access & Regulatory Affairs in China 2013

Topics

• Strategies for accessing the pharma market in China
• Biggest challenges in Chinese market access and regulatory affairs
• Filing variations renewals
• Latest healthcare reform and its implications for the pharma Industry

Who should Attend

Professionals from pharmaceutical and biotechnology companies responsible for:

• Emerging Markets (APAC, CHINA,TAIWAN)
• Market Access
• Health Economics and Outcomes Research
• Global Regulatory Affairs
• Supply Chain Management
• Business Analysis and Development
• Strategic Planning
• Government Affairs